Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Q1 2026 delivered $19.80 billion in revenue, beating the $17.80 billion consensus, with non-GAAP EPS of $8.55 versus the $6.79 estimate
Cell 2017;171:27385
Discontinuation Rates TRIUMPH-1's 11.3% rate is an improvement over TRIUMPH-4's 18.2%, suggesting the general obesity population tolerates retatrutide meaningfully better than the older, more comorbid OA population
The researchers said this reduction in AFib risk remained consistent, regardless of the level of weight change
5 Gene expression analysis (PubMed)GHK-mediated modulation of gene expression toward tissue repair in cultured human cells
US$ 24.48
US$ 25.16
US$ 23.67
US$ 28.86
